Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.

ABSTRACT:

Objectives

Treatments for SSc-associated interstitial lung disease (SSc-ILD) differ in attributes, i.e. mode of administration, adverse events (AEs) and efficacy. As physicians and patients may perceive treatments differently, shared decision-making can be essential for optimal treatment provision. We therefore aimed to quantify patient preferences for different treatment attributes.

Methods

Seven SSc-ILD attributes were identified from mixed-methods research and clinician input: mode of administration, shortness of breath, skin tightness, cough, tiredness, risk of gastrointestinal AEs (GI-AEs) and risk of serious and non-serious infections. Patients with SSc-ILD completed an online discrete choice experiment (DCE) in which they were asked to repeatedly choose between two al

SUBMITTER: Bruni C 

PROVIDER: S-EPMC9536797 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature